Receptor binding ligands, their use in the detection of cells with biological interest
US-9791435-B2 · Oct 17, 2017 · US
US9618508B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9618508-B2 |
| Application number | US-201113994536-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 14, 2011 |
| Priority date | Dec 14, 2010 |
| Publication date | Apr 11, 2017 |
| Grant date | Apr 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention utilizes the techniques and instruments which are typically used in flow cytometry (FC) as a tool for analyzing adsorbed materials. Thus the invention provides a method for analyzing a component which is adsorbed to an insoluble metal salt, comprising steps of: (i) labelling the adsorbed component with a binding reagent; and (ii) analyzing the labelled adsorbed component by flow cytometry.
Opening claim text (preview).
The invention claimed is: 1. A flow cytometric method for measuring the amount of a component adsorbed to an insoluble metal salt, wherein the measuring comprises the steps of: (i) labelling the adsorbed component with a labelled binding reagent to produce a labelled component; and (ii) measuring the amount of the labelled adsorbed component on the insoluble metal salt particles by flow cytometry. 2. The method according to claim 1 further comprising, before analysis, the step of adsorbing the component to the insoluble metal salt. 3. The method according to claim 1 , wherein the labelling step is preceded by a blocking step. 4. The method according to claim 1 , wherein the component is a polypeptide antigen. 5. The method according to claim 1 , wherein the component is an immunopotentiator. 6. The method according to claim 1 , wherein the metal salt is an aluminium salt. 7. The method according to claim 6 , wherein the aluminium salt comprises an aluminium hydroxide and/or an aluminium phosphate. 8. The method according to claim 1 , wherein the labelled binding reagent comprises an antibody. 9. The method according to claim 8 , wherein the labelled binding reagent comprises a primary antibody and a secondary antibody. 10. The method according to claim 1 , wherein the labelled binding reagent comprises a fluorophore. 11. A method for analysing the distribution of a component which is adsorbed to an insoluble metal salt particles, comprising steps of: (i) labelling the adsorbed component with a labelled binding reagent to produce a labelled adsorbed component; and (ii) analysing the distribution of the labelled adsorbed component on the insoluble metal salt particles by flow cytometry. 12. The method according to claim 11 further comprising, before analysis, the step of adsorbing the component to the insoluble metal salt particles. 13. The method according to claim 11 , wherein the labelling step is preceded by a blocking step. 14. The method according to claim 11 , wherein the component is a polypeptide antigen. 15. The method according to claim 11 , wherein the component is an immunopotentiator. 16. The method according to claim 11 , wherein the metal salt particles are aluminium metal salt particles. 17. The method according to claim 16 , wherein the aluminium metal salt particles comprises aluminium hydroxide particles and/or an aluminium phosphate particles. 18. The method according to claim 17 , wherein the labelled binding reagent comprises antibody. 19. The method according to claim 18 , wherein the labelled binding reagent comprises a primary antibody and a secondary antibody. 20. The method according to claim 11 , wherein the labelled binding reagent comprises a fluorophore.
with separation of immune complex from unbound antigen or antibody · CPC title
Bacteria · CPC title
involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)} · CPC title
involving inorganic compounds or pH · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.